Literature DB >> 3884038

Pre-enucleation irradiation of uveal melanoma.

D H Char, T L Phillips.   

Abstract

The relative efficacy of various types of treatment in preventing metastatic uveal melanoma is unclear. We have performed a phase I-II non-randomised trial to determine if patients with large (greater than 15 mm in diameter or greater than 5 mm in thickness) uveal melanomas would benefit from pre-enucleation irradiation. Twenty-eight patients were treated between 1978 and 1983 by means of 5 X 5 cm anterior wedge pair ports on a 4 me V linear accelerator. Each patient received five 4 gray (400 rad) fractions over a five-day period for a total of 20 Gy. Enucleation was performed by a single surgeon within five days after treatment. The mean follow-up of the patients was 24 months (range 7-54 months). All melanomas were histologically confirmed. Four patients (14%) have developed metastatic tumour with a mean interval between diagnosis and death of 25 months. No significant perioperative or long-term morbidity was observed.

Entities:  

Mesh:

Year:  1985        PMID: 3884038      PMCID: PMC1040557          DOI: 10.1136/bjo.69.3.177

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial.

Authors:  W D Rider; J A Palmer; L J Mahoney; C T Robertson
Journal:  Can J Surg       Date:  1977-07       Impact factor: 2.089

2.  Preoperative radiotherapy for adenocarcinoma of the rectosigmoid.

Authors:  K R Stevens; C V Allen; W S Fletcher
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

3.  Treatment of malignant choroidal melanomas with photocoagulation. Evaluation of 10-year follow-up data.

Authors:  M H Vogel
Journal:  Am J Ophthalmol       Date:  1972-07       Impact factor: 5.258

4.  Malignant melanoblastoma of the choroid.

Authors:  H B Stallard
Journal:  Bibl Ophthalmol       Date:  1968

5.  Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study.

Authors:  E S Gragoudas; M Goitein; L Verhey; J Munzenreider; M Urie; H Suit; A Koehler
Journal:  Arch Ophthalmol       Date:  1982-06

6.  Bladder cancer: superiority of preoperative irradiation and cystectomy in clinical stages B2 and C.

Authors:  L S Miller
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

7.  The potential for adjuvant radiotherapy in choroidal melanoma.

Authors:  D H Char; T L Phillips
Journal:  Arch Ophthalmol       Date:  1982-02

8.  The management of small choroidal melanomas.

Authors:  D H Char
Journal:  Surv Ophthalmol       Date:  1978 May-Jun       Impact factor: 6.048

9.  Metastatic choroidal melanoma.

Authors:  D H Char
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

10.  Diagnostic modalities in choroidal melanoma.

Authors:  D H Char; R D Stone; A R Irvine; J B Crawford; G F Hilton; L I Lonn; A Schwartz
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

  10 in total
  2 in total

1.  Modelling uveal melanoma.

Authors:  A J Foss; I A Cree; P J Dolin; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  In vitro viability of choroidal melanomata following pre-enucleation irradiation.

Authors:  U Chakravarthy; L Frew; T A Gardiner; D B Archer
Journal:  Int Ophthalmol       Date:  1991-09       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.